These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24121191)

  • 61. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
    Crijns H; Vanheule V; Proost P
    Front Immunol; 2020; 11():483. PubMed ID: 32296423
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glycosaminoglycan and Proteoglycan-Based Biomaterials: Current Trends and Future Perspectives.
    Rnjak-Kovacina J; Tang F; Whitelock JM; Lord MS
    Adv Healthc Mater; 2018 Mar; 7(6):e1701042. PubMed ID: 29210510
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular Dynamics Simulation-Based Prediction of Glycosaminoglycan Interactions with Drug Molecules.
    Maszota-Zieleniak M; Samsonov SA
    Methods Mol Biol; 2024; 2714():143-153. PubMed ID: 37676597
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Dilemma in the Glycosaminoglycan-Based Therapy: Synthetic or Naturally Unique Molecules?
    Pomin VH
    Med Res Rev; 2015 Nov; 35(6):1195-219. PubMed ID: 26152885
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chemically modified glycosaminoglycan derivatives as building blocks for biomaterial coatings and hydrogels.
    Schnabelrauch M; Schiller J; Möller S; Scharnweber D; Hintze V
    Biol Chem; 2021 Oct; 402(11):1385-1395. PubMed ID: 34008374
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The structure of glycosaminoglycans and their interactions with proteins.
    Gandhi NS; Mancera RL
    Chem Biol Drug Des; 2008 Dec; 72(6):455-82. PubMed ID: 19090915
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of structural motifs for interactions between glycosaminoglycans and proteins.
    Yang J; Chi L
    Carbohydr Res; 2017 Nov; 452():54-63. PubMed ID: 29065343
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode.
    Chabrol E; Nurisso A; Daina A; Vassal-Stermann E; Thepaut M; Girard E; Vivès RR; Fieschi F
    PLoS One; 2012; 7(11):e50722. PubMed ID: 23226363
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glycosaminoglycan glycomics using mass spectrometry.
    Zaia J
    Mol Cell Proteomics; 2013 Apr; 12(4):885-92. PubMed ID: 23325770
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Roles of glycosaminoglycans as regulators of ligand/receptor complexes.
    Smock RG; Meijers R
    Open Biol; 2018 Oct; 8(10):. PubMed ID: 30282658
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A New C-Xyloside induces modifications of GAG expression, structure and functional properties.
    Vassal-Stermann E; Duranton A; Black AF; Azadiguian G; Demaude J; Lortat-Jacob H; Breton L; Vivès RR
    PLoS One; 2012; 7(10):e47933. PubMed ID: 23110134
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Influences of Sulphation, Salt Type, and Salt Concentration on the Structural Heterogeneity of Glycosaminoglycans.
    Samantray S; Olubiyi OO; Strodel B
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768961
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cell-penetrating compounds preferentially bind glycosaminoglycans over plasma membrane lipids in a charge density- and stereochemistry-dependent manner.
    Prevette LE; Benish NC; Schoenecker AR; Braden KJ
    Biophys Chem; 2015 Dec; 207():40-50. PubMed ID: 26356251
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy.
    Berdiaki A; Neagu M; Giatagana EM; Kuskov A; Tsatsakis AM; Tzanakakis GN; Nikitovic D
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800172
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sulfated glycosaminoglycans as promising artificial extracellular matrix components to improve the regeneration of tissues.
    Schnabelrauch M; Scharnweber D; Schiller J
    Curr Med Chem; 2013; 20(20):2501-23. PubMed ID: 23521682
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of a microtiter plate-based glycosaminoglycan array for the investigation of glycosaminoglycan-protein interactions.
    Marson A; Robinson DE; Brookes PN; Mulloy B; Wiles M; Clark SJ; Fielder HL; Collinson LJ; Cain SA; Kielty CM; McArthur S; Buttle DJ; Short RD; Whittle JD; Day AJ
    Glycobiology; 2009 Dec; 19(12):1537-46. PubMed ID: 19729381
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glycosaminoglycan chain analysis and characterization (glycosylation/epimerization).
    Mizumoto S; Sugahara K
    Methods Mol Biol; 2012; 836():99-115. PubMed ID: 22252630
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus.
    Vanheule V; Vervaeke P; Mortier A; Noppen S; Gouwy M; Snoeck R; Andrei G; Van Damme J; Liekens S; Proost P
    Biochem Pharmacol; 2016 Jan; 100():73-85. PubMed ID: 26551597
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hungatella hathewayi, an Efficient Glycosaminoglycan-Degrading
    Rawat PS; Li Y; Zhang W; Meng X; Liu W
    Appl Environ Microbiol; 2022 Nov; 88(22):e0154622. PubMed ID: 36342199
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The glycosaminoglycan interactome 2.0.
    Vallet SD; Berthollier C; Ricard-Blum S
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1271-C1278. PubMed ID: 35544698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.